TF
Insider
Todd Foley
DirectorTodd Foley (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Aktis Oncology, Inc. (AKTS). Across 1 priced purchase filing, the average 21-session return was -20.7% from execution and -15.6% from disclosure (delay-adjusted; derived). The largest single filing was $4.2M of AKTS (232,870 sh × $18.00, as filed), executed Jan 12.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-20.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-15.6%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.2M
shares × price, as filed
Last traded
Jan 12
Filed Jan 14
Median ADV $8.9M across their filed names
Open performance→Volume by month
Buys $4.2M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
AKTSRecent filings
AKTSPURCHASE
Aktis Oncology, Inc.
View filing →
$4.2M232,870 sh × $18.00
Exec Jan 12
Filed Jan 14 · 6:20 PM ET